Table 1.
Plan characteristics (n = 20) | Number (percentage) or median (range) |
---|---|
Lobe | |
RUL | 9 (45%) |
LLL | 5 (25%) |
LUL | 2 (10%) |
RML | 2 (10%) |
RLL | 1 (5%) |
Lingula | 1 (5%) |
Location | |
Peripheral | 18 (90%) |
Central | 2 (10%) |
Total bilateral lung volume | 3421 mL (2298 to 6228 mL) |
GTV greatest axial diameter | 3.5 cm (2.1 to 5.5 cm) |
GTV volume | 14.5 mL (3.6 to 59.9 mL) |
ITV volume | 23.3 mL (4.6 to 77.7 mL) |
ITV subtract GTV volume | 5.5 mL (1.0 to 22.3 mL) |
Tumor motion | |
Superior–inferior | 4.5 mm (0 to 20 mm) |
Anterior–posterior | 3 mm (0 to 9 mm) |
Left–right | 2 mm (0 to 8 mm) |
Prescription dose and fractions | |
60 Gy in 5 fractions | 2 (10%) |
54 Gy in 3 fractions | 3 (15%) |
50 Gy in 5 fractions | 7 (35%) |
48 Gy in 4 fractions | 2 (10%) |
42.5 Gy in 5 fractions | 1 (5%) |
37.5 Gy in 3 fractions | 1 (5%) |
25 Gy in 1 fraction | 2 (10%) |
24 Gy in 1 fraction | 1 (5%) |
22 Gy in 1 fraction | 1 (5%) |
Prescription EQD2 (α/β = 3) | 130 Gy (97.75 to 226.8 Gy) |
Isotropic PTVRTT margin | |
5.0 mm | 14 (70%) |
2.5 mm | 4 (20%) |
2.0 mm | 2 (10%) |